VIB Vermögen AG
VIB Vermögen AG (VIH1.DE) Stock Competitors & Peer Comparison
See (VIH1.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Real Estate - Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VIH1.DE | €7.90 | +4.77% | 259.1M | 6.53 | €1.20 | +0.51% |
| VNA.F | €22.28 | +3.34% | 18.9B | 6.91 | €3.23 | +5.47% |
| VNA.DE | €22.41 | +3.94% | 18.9B | 6.90 | €3.23 | +5.47% |
| VTWR.DE | €32.50 | +0.00% | 16.4B | 43.33 | €0.75 | N/A |
| VTWR.F | €32.40 | +0.00% | 16.4B | 43.20 | €0.75 | N/A |
| O5G.DE | €0.74 | +1.38% | 6.1B | -72.50 | -€0.01 | N/A |
| EFE.F | €16.56 | +3.31% | 5.2B | 16.15 | €1.03 | +1.92% |
| G24.DE | €66.35 | +0.53% | 4.6B | 19.52 | €3.33 | +2.03% |
| G24.SG | €65.95 | -0.08% | 4.5B | N/A | N/A | +2.03% |
| LEG.SG | €57.55 | +1.86% | 4.4B | N/A | N/A | +4.69% |
Stock Comparison
VIH1.DE vs VNA.F Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, VNA.F has a market cap of 18.9B. Regarding current trading prices, VIH1.DE is priced at €7.90, while VNA.F trades at €22.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas VNA.F's P/E ratio is 6.91. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to VNA.F's ROE of +0.15%. Regarding short-term risk, VIH1.DE is more volatile compared to VNA.F. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check VNA.F's competition here
VIH1.DE vs VNA.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, VNA.DE has a market cap of 18.9B. Regarding current trading prices, VIH1.DE is priced at €7.90, while VNA.DE trades at €22.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas VNA.DE's P/E ratio is 6.90. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to VNA.DE's ROE of +0.15%. Regarding short-term risk, VIH1.DE is more volatile compared to VNA.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check VNA.DE's competition here
VIH1.DE vs VTWR.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, VTWR.DE has a market cap of 16.4B. Regarding current trading prices, VIH1.DE is priced at €7.90, while VTWR.DE trades at €32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas VTWR.DE's P/E ratio is 43.33. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to VTWR.DE's ROE of +0.09%. Regarding short-term risk, VIH1.DE is more volatile compared to VTWR.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check VTWR.DE's competition here
VIH1.DE vs VTWR.F Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, VTWR.F has a market cap of 16.4B. Regarding current trading prices, VIH1.DE is priced at €7.90, while VTWR.F trades at €32.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas VTWR.F's P/E ratio is 43.20. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to VTWR.F's ROE of +0.09%. Regarding short-term risk, VIH1.DE is more volatile compared to VTWR.F. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check VTWR.F's competition here
VIH1.DE vs O5G.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, O5G.DE has a market cap of 6.1B. Regarding current trading prices, VIH1.DE is priced at €7.90, while O5G.DE trades at €0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas O5G.DE's P/E ratio is -72.50. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to O5G.DE's ROE of -0.00%. Regarding short-term risk, VIH1.DE is more volatile compared to O5G.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check O5G.DE's competition here
VIH1.DE vs EFE.F Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, EFE.F has a market cap of 5.2B. Regarding current trading prices, VIH1.DE is priced at €7.90, while EFE.F trades at €16.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas EFE.F's P/E ratio is 16.15. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to EFE.F's ROE of +0.10%. Regarding short-term risk, VIH1.DE is more volatile compared to EFE.F. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check EFE.F's competition here
VIH1.DE vs G24.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, G24.DE has a market cap of 4.6B. Regarding current trading prices, VIH1.DE is priced at €7.90, while G24.DE trades at €66.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas G24.DE's P/E ratio is 19.52. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to G24.DE's ROE of +0.09%. Regarding short-term risk, VIH1.DE is more volatile compared to G24.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check G24.DE's competition here
VIH1.DE vs G24.SG Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, G24.SG has a market cap of 4.5B. Regarding current trading prices, VIH1.DE is priced at €7.90, while G24.SG trades at €65.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas G24.SG's P/E ratio is N/A. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to G24.SG's ROE of +0.09%. Regarding short-term risk, VIH1.DE is more volatile compared to G24.SG. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check G24.SG's competition here
VIH1.DE vs LEG.SG Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, LEG.SG has a market cap of 4.4B. Regarding current trading prices, VIH1.DE is priced at €7.90, while LEG.SG trades at €57.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas LEG.SG's P/E ratio is N/A. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to LEG.SG's ROE of +0.18%. Regarding short-term risk, VIH1.DE is more volatile compared to LEG.SG. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check LEG.SG's competition here
VIH1.DE vs LEG.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, LEG.DE has a market cap of 4.4B. Regarding current trading prices, VIH1.DE is priced at €7.90, while LEG.DE trades at €57.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas LEG.DE's P/E ratio is 3.42. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to LEG.DE's ROE of +0.18%. Regarding short-term risk, VIH1.DE is more volatile compared to LEG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check LEG.DE's competition here
VIH1.DE vs TEG.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, TEG.DE has a market cap of 2.7B. Regarding current trading prices, VIH1.DE is priced at €7.90, while TEG.DE trades at €14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas TEG.DE's P/E ratio is 28.02. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to TEG.DE's ROE of +0.03%. Regarding short-term risk, VIH1.DE is more volatile compared to TEG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check TEG.DE's competition here
VIH1.DE vs AT1.F Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, AT1.F has a market cap of 2.7B. Regarding current trading prices, VIH1.DE is priced at €7.90, while AT1.F trades at €2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas AT1.F's P/E ratio is 4.04. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to AT1.F's ROE of +0.08%. Regarding short-term risk, VIH1.DE is more volatile compared to AT1.F. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check AT1.F's competition here
VIH1.DE vs AT1.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, AT1.DE has a market cap of 2.7B. Regarding current trading prices, VIH1.DE is priced at €7.90, while AT1.DE trades at €2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas AT1.DE's P/E ratio is 4.03. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to AT1.DE's ROE of +0.08%. Regarding short-term risk, VIH1.DE is more volatile compared to AT1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check AT1.DE's competition here
VIH1.DE vs 6CL.F Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, 6CL.F has a market cap of 2.4B. Regarding current trading prices, VIH1.DE is priced at €7.90, while 6CL.F trades at €13.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas 6CL.F's P/E ratio is 31.43. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to 6CL.F's ROE of +0.07%. Regarding short-term risk, VIH1.DE is more volatile compared to 6CL.F. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check 6CL.F's competition here
VIH1.DE vs GYC.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, GYC.DE has a market cap of 1.7B. Regarding current trading prices, VIH1.DE is priced at €7.90, while GYC.DE trades at €9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas GYC.DE's P/E ratio is 3.62. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to GYC.DE's ROE of +0.12%. Regarding short-term risk, VIH1.DE is more volatile compared to GYC.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check GYC.DE's competition here
VIH1.DE vs T1L.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, T1L.DE has a market cap of 1.6B. Regarding current trading prices, VIH1.DE is priced at €7.90, while T1L.DE trades at €22.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas T1L.DE's P/E ratio is -65.59. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to T1L.DE's ROE of -0.02%. Regarding short-term risk, Volatility data is not available for a full comparison. VIH1.DE has daily volatility of 5.39 and T1L.DE has daily volatility of N/A.Check T1L.DE's competition here
VIH1.DE vs DEQ.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, DEQ.DE has a market cap of 1.5B. Regarding current trading prices, VIH1.DE is priced at €7.90, while DEQ.DE trades at €19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas DEQ.DE's P/E ratio is 11.24. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to DEQ.DE's ROE of +0.07%. Regarding short-term risk, VIH1.DE is more volatile compared to DEQ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check DEQ.DE's competition here
VIH1.DE vs 6N5.F Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, 6N5.F has a market cap of 1.1B. Regarding current trading prices, VIH1.DE is priced at €7.90, while 6N5.F trades at €13.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas 6N5.F's P/E ratio is 11.75. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to 6N5.F's ROE of +0.10%. Regarding short-term risk, VIH1.DE is more volatile compared to 6N5.F. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check 6N5.F's competition here
VIH1.DE vs ADL.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, ADL.DE has a market cap of 980.4M. Regarding current trading prices, VIH1.DE is priced at €7.90, while ADL.DE trades at €8.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas ADL.DE's P/E ratio is -2.60. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to ADL.DE's ROE of -0.30%. Regarding short-term risk, VIH1.DE is more volatile compared to ADL.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check ADL.DE's competition here
VIH1.DE vs A4Y0.F Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, A4Y0.F has a market cap of 800.2M. Regarding current trading prices, VIH1.DE is priced at €7.90, while A4Y0.F trades at €80.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas A4Y0.F's P/E ratio is -0.04. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to A4Y0.F's ROE of N/A. Regarding short-term risk, VIH1.DE is more volatile compared to A4Y0.F. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check A4Y0.F's competition here
VIH1.DE vs PAT.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, PAT.DE has a market cap of 615.6M. Regarding current trading prices, VIH1.DE is priced at €7.90, while PAT.DE trades at €7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas PAT.DE's P/E ratio is 19.24. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to PAT.DE's ROE of +0.02%. Regarding short-term risk, VIH1.DE is more volatile compared to PAT.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check PAT.DE's competition here
VIH1.DE vs DEF.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, DEF.DE has a market cap of 121M. Regarding current trading prices, VIH1.DE is priced at €7.90, while DEF.DE trades at €24.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas DEF.DE's P/E ratio is 25.98. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to DEF.DE's ROE of +0.10%. Regarding short-term risk, VIH1.DE is more volatile compared to DEF.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check DEF.DE's competition here
VIH1.DE vs FC9.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, FC9.DE has a market cap of 114.5M. Regarding current trading prices, VIH1.DE is priced at €7.90, while FC9.DE trades at €11.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas FC9.DE's P/E ratio is 5.20. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to FC9.DE's ROE of +0.15%. Regarding short-term risk, VIH1.DE is more volatile compared to FC9.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check FC9.DE's competition here
VIH1.DE vs DMRE.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, DMRE.DE has a market cap of 52.8M. Regarding current trading prices, VIH1.DE is priced at €7.90, while DMRE.DE trades at €0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas DMRE.DE's P/E ratio is -0.60. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to DMRE.DE's ROE of -0.54%. Regarding short-term risk, VIH1.DE is more volatile compared to DMRE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check DMRE.DE's competition here
VIH1.DE vs IC8.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, IC8.DE has a market cap of 38.7M. Regarding current trading prices, VIH1.DE is priced at €7.90, while IC8.DE trades at €0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas IC8.DE's P/E ratio is -5.62. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to IC8.DE's ROE of -0.23%. Regarding short-term risk, VIH1.DE is more volatile compared to IC8.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check IC8.DE's competition here
VIH1.DE vs CCAP.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, CCAP.DE has a market cap of 38.5M. Regarding current trading prices, VIH1.DE is priced at €7.90, while CCAP.DE trades at €0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas CCAP.DE's P/E ratio is -0.02. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to CCAP.DE's ROE of -2.69%. Regarding short-term risk, VIH1.DE is less volatile compared to CCAP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for VIH1.DE.Check CCAP.DE's competition here
VIH1.DE vs WFS.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, WFS.DE has a market cap of 34.7M. Regarding current trading prices, VIH1.DE is priced at €7.90, while WFS.DE trades at €0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas WFS.DE's P/E ratio is 1.48. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to WFS.DE's ROE of -1.08%. Regarding short-term risk, VIH1.DE is more volatile compared to WFS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check WFS.DE's competition here
VIH1.DE vs ADJ.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, ADJ.DE has a market cap of 24.7M. Regarding current trading prices, VIH1.DE is priced at €7.90, while ADJ.DE trades at €0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas ADJ.DE's P/E ratio is 0.05. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to ADJ.DE's ROE of -0.99%. Regarding short-term risk, VIH1.DE is more volatile compared to ADJ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check ADJ.DE's competition here
VIH1.DE vs PBY.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, PBY.DE has a market cap of 22.3M. Regarding current trading prices, VIH1.DE is priced at €7.90, while PBY.DE trades at €2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas PBY.DE's P/E ratio is -0.16. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to PBY.DE's ROE of -0.93%. Regarding short-term risk, VIH1.DE is more volatile compared to PBY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check PBY.DE's competition here
VIH1.DE vs AMM.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, AMM.DE has a market cap of 18.2M. Regarding current trading prices, VIH1.DE is priced at €7.90, while AMM.DE trades at €0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas AMM.DE's P/E ratio is -0.69. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to AMM.DE's ROE of -0.31%. Regarding short-term risk, VIH1.DE is more volatile compared to AMM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check AMM.DE's competition here
VIH1.DE vs DGR.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, DGR.DE has a market cap of 9M. Regarding current trading prices, VIH1.DE is priced at €7.90, while DGR.DE trades at €5.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas DGR.DE's P/E ratio is -19.31. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to DGR.DE's ROE of -0.08%. Regarding short-term risk, VIH1.DE is more volatile compared to DGR.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check DGR.DE's competition here
VIH1.DE vs UIJ.MU Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, UIJ.MU has a market cap of 8.8M. Regarding current trading prices, VIH1.DE is priced at €7.90, while UIJ.MU trades at €4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas UIJ.MU's P/E ratio is 454.00. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to UIJ.MU's ROE of -0.04%. Regarding short-term risk, VIH1.DE is more volatile compared to UIJ.MU. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check UIJ.MU's competition here
VIH1.DE vs A4Y.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, A4Y.DE has a market cap of 7.1M. Regarding current trading prices, VIH1.DE is priced at €7.90, while A4Y.DE trades at €0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas A4Y.DE's P/E ratio is -0.09. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to A4Y.DE's ROE of -0.06%. Regarding short-term risk, VIH1.DE is less volatile compared to A4Y.DE. This indicates potentially lower risk in terms of short-term price fluctuations for VIH1.DE.Check A4Y.DE's competition here
VIH1.DE vs AMMN.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, AMMN.DE has a market cap of 5.3M. Regarding current trading prices, VIH1.DE is priced at €7.90, while AMMN.DE trades at €0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas AMMN.DE's P/E ratio is -0.46. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to AMMN.DE's ROE of -0.31%. Regarding short-term risk, VIH1.DE is more volatile compared to AMMN.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check AMMN.DE's competition here
VIH1.DE vs M8H.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, M8H.DE has a market cap of 4.4M. Regarding current trading prices, VIH1.DE is priced at €7.90, while M8H.DE trades at €0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas M8H.DE's P/E ratio is 3.70. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to M8H.DE's ROE of +0.03%. Regarding short-term risk, VIH1.DE is less volatile compared to M8H.DE. This indicates potentially lower risk in terms of short-term price fluctuations for VIH1.DE.Check M8H.DE's competition here
VIH1.DE vs TTO.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, TTO.DE has a market cap of 3.7M. Regarding current trading prices, VIH1.DE is priced at €7.90, while TTO.DE trades at €0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas TTO.DE's P/E ratio is -0.19. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to TTO.DE's ROE of -0.48%. Regarding short-term risk, VIH1.DE is less volatile compared to TTO.DE. This indicates potentially lower risk in terms of short-term price fluctuations for VIH1.DE.Check TTO.DE's competition here
VIH1.DE vs PAG.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, PAG.DE has a market cap of 2.3M. Regarding current trading prices, VIH1.DE is priced at €7.90, while PAG.DE trades at €0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas PAG.DE's P/E ratio is -0.01. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to PAG.DE's ROE of -0.69%. Regarding short-term risk, VIH1.DE is less volatile compared to PAG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for VIH1.DE.Check PAG.DE's competition here
VIH1.DE vs CORE.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, CORE.DE has a market cap of 672.1K. Regarding current trading prices, VIH1.DE is priced at €7.90, while CORE.DE trades at €0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas CORE.DE's P/E ratio is -0.06. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to CORE.DE's ROE of -0.41%. Regarding short-term risk, VIH1.DE is less volatile compared to CORE.DE. This indicates potentially lower risk in terms of short-term price fluctuations for VIH1.DE.Check CORE.DE's competition here
VIH1.DE vs VROS.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, VROS.DE has a market cap of 563.8K. Regarding current trading prices, VIH1.DE is priced at €7.90, while VROS.DE trades at €0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas VROS.DE's P/E ratio is -0.15. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to VROS.DE's ROE of -0.50%. Regarding short-term risk, VIH1.DE is less volatile compared to VROS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for VIH1.DE.Check VROS.DE's competition here
VIH1.DE vs PAG.F Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, PAG.F has a market cap of 397.1K. Regarding current trading prices, VIH1.DE is priced at €7.90, while PAG.F trades at €0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas PAG.F's P/E ratio is -0.00. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to PAG.F's ROE of -0.69%. Regarding short-term risk, VIH1.DE is more volatile compared to PAG.F. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check PAG.F's competition here
VIH1.DE vs HHH.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, HHH.DE has a market cap of 0. Regarding current trading prices, VIH1.DE is priced at €7.90, while HHH.DE trades at €0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas HHH.DE's P/E ratio is N/A. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to HHH.DE's ROE of -2.45%. Regarding short-term risk, VIH1.DE is less volatile compared to HHH.DE. This indicates potentially lower risk in terms of short-term price fluctuations for VIH1.DE.Check HHH.DE's competition here
VIH1.DE vs TLG.DE Comparison April 2026
VIH1.DE plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VIH1.DE stands at 259.1M. In comparison, TLG.DE has a market cap of 0. Regarding current trading prices, VIH1.DE is priced at €7.90, while TLG.DE trades at €30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VIH1.DE currently has a P/E ratio of 6.53, whereas TLG.DE's P/E ratio is 7.89. In terms of profitability, VIH1.DE's ROE is +0.05%, compared to TLG.DE's ROE of +0.14%. Regarding short-term risk, VIH1.DE is more volatile compared to TLG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for VIH1.DE.Check TLG.DE's competition here